NVLIX
Price
$68.79
Change
-$0.08 (-0.12%)
Updated
Dec 3 closing price
Net Assets
870.28M
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

NVLIX vs VIGRX

Header iconNVLIX vs VIGRX Comparison
Open Charts NVLIX vs VIGRXBanner chart's image
Nuveen Winslow Large-Cap Growth ESG I
Price$68.79
Change-$0.08 (-0.12%)
VolumeN/A
Net Assets870.28M
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
NVLIX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
NVLIX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVLIX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. NVLIX (870M). VIGRX pays higher dividends than NVLIX: VIGRX (0.30) vs NVLIX (0.00). NVLIX was incepted earlier than VIGRX: NVLIX (17 years) vs VIGRX (33 years). NVLIX (0.83) is less costly to investors than VIGRX (0.17). NVLIX is a more actively managed with annual turnover of: 56.00 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than NVLIX: VIGRX (3000) vs NVLIX (100000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. NVLIX (-2.05). VIGRX return over 5 years is better than : 99.11 vs. NVLIX (33.21).
NVLIXVIGRXNVLIX / VIGRX
Total Expense Ratio0.650.17382%
Annual Report Gross Expense Ratio0.830.17488%
Fund Existence17 years33 years-
Gain YTD13.60919.76469%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets870M357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year-2.0518.49-11%
Returns for 3 years50.13110.8245%
Returns for 5 years33.2199.1134%
Returns for 10 years44.10349.1313%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT